Aza-arylpiperazines
The present invention refers to chemical compounds of formula (I), as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R4 have the significance given in claim 1. They can be used in the form of pharmaceutical preparations for the treatment or prevention of disord...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
16.12.2003
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention refers to chemical compounds of formula (I), as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R4 have the significance given in claim 1. They can be used in the form of pharmaceutical preparations for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes, obesity and sleep apnoea. |
---|---|
AbstractList | The present invention refers to chemical compounds of formula (I), as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R4 have the significance given in claim 1. They can be used in the form of pharmaceutical preparations for the treatment or prevention of disorders of the central nervous system, damage to the central nervous system, cardiovascular disorders, gastrointestinal disorders, diabetes, obesity and sleep apnoea. |
Author | STEPHAN ROEVER BLENCH, TOBY JONATHAN HANS RICHTER BENTLEY, JONATHAN MARK HEBEISEN, PAUL MONCK, NATHANIEL JULIUS THOMAS JONATHAN RICHARD ANTHONY ROFFEY SVEN TAYLOR ADAMS, DAVID REGINALD |
Author_xml | – fullname: HANS RICHTER – fullname: STEPHAN ROEVER – fullname: SVEN TAYLOR – fullname: JONATHAN RICHARD ANTHONY ROFFEY – fullname: ADAMS, DAVID REGINALD – fullname: BLENCH, TOBY JONATHAN – fullname: HEBEISEN, PAUL – fullname: BENTLEY, JONATHAN MARK – fullname: MONCK, NATHANIEL JULIUS THOMAS |
BookMark | eNrjYmDJy89L5WQQdqxK1E0sqswpyCxILUqsysxLLeZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEh4UYGBsYG5mYWxo7GxKgBAAXYIpE |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | TW200307683A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_TW200307683A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:21:02 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Chinese English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_TW200307683A3 |
Notes | Application Number: TW200392101825 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20031216&DB=EPODOC&CC=TW&NR=200307683A |
ParticipantIDs | epo_espacenet_TW200307683A |
PublicationCentury | 2000 |
PublicationDate | 20031216 |
PublicationDateYYYYMMDD | 2003-12-16 |
PublicationDate_xml | – month: 12 year: 2003 text: 20031216 day: 16 |
PublicationDecade | 2000 |
PublicationYear | 2003 |
RelatedCompanies | F. HOFFMANN-LA ROCHE AG VERNALIS RESEARCH LIMITED |
RelatedCompanies_xml | – name: F. HOFFMANN-LA ROCHE AG – name: VERNALIS RESEARCH LIMITED |
Score | 2.6854692 |
Snippet | The present invention refers to chemical compounds of formula (I), as well as pharmaceutically acceptable salts, solvates and esters thereof, wherein R1 to R4... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Aza-arylpiperazines |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20031216&DB=EPODOC&locale=&CC=TW&NR=200307683A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUkyNEw2BO1uNwJGg0lqcqJukkVSkq6FkXGiabKZcYoF-Lo3Xz8zj1ATrwjTCCaGLNheGPA5oeXgwxGBOSoZmN9LwOV1AWIQywW8trJYPykTKJRv7xZi66IG6x0bGxoZmqm5ONm6Bvi7-DurOTvbhoSr-QWB5UCTTsaOzAyswGa0OSg3uIY5gXalFCBXKW6CDGwBQNPySoQYmKoyhBk4nWE3rwkzcPhCJ7yBTGjeKxZhEHasStRNLKrMKcgsSC0CnwpdLMqg6OYa4uyhCzQ9Hu6V-JBwhEOMxRhYgF38VAkGhdQUo0Rjk9REIwtTc5NUy0RgI8LI0jw10TLNNM0kMclMkkEKtzlS-CSlGbggy8-MdA3NZBhYSopKU2WB1WhJkhzY_wDnR3YE |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSUkyNEw2BO1uNwJGg0lqcqJukkVSkq6FkXGiabKZcYoF-Lo3Xz8zj1ATrwjTCCaGLNheGPA5oeXgwxGBOSoZmN9LwOV1AWIQywW8trJYPykTKJRv7xZi66IG6x0bGxoZmqm5ONm6Bvi7-DurOTvbhoSr-QWB5UCTTsaOzAysQNoclBtcw5xAu1IKkKsUN0EGtgCgaXklQgxMVRnCDJzOsJvXhBk4fKET3kAmNO8VizAIO1Yl6iYWVeYUZBakFoFPhS4WZVB0cw1x9tAFmh4P90p8SDjCIcZiDCzALn6qBINCaopRorFJaqKRham5SaplIrARYWRpnppomWaaZpKYZCbJIIXbHCl8kvIMnB4hvj7xPp5-3tIMXJClaEa6hmYyDCwlRaWpssAqtSRJDhwWAJprePc |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Aza-arylpiperazines&rft.inventor=HANS+RICHTER&rft.inventor=STEPHAN+ROEVER&rft.inventor=SVEN+TAYLOR&rft.inventor=JONATHAN+RICHARD+ANTHONY+ROFFEY&rft.inventor=ADAMS%2C+DAVID+REGINALD&rft.inventor=BLENCH%2C+TOBY+JONATHAN&rft.inventor=HEBEISEN%2C+PAUL&rft.inventor=BENTLEY%2C+JONATHAN+MARK&rft.inventor=MONCK%2C+NATHANIEL+JULIUS+THOMAS&rft.date=2003-12-16&rft.externalDBID=A&rft.externalDocID=TW200307683A |